AccuDava Success Story
Click for PDF


“The Brink SBDC and Dr. Martin Kleckner have been invaluable in the success and progress of AccuDava. They dedicated many hours to reviewing and giving advice on our SBIR grant application to the National Cancer Institute, which was successfully awarded $300,000. Their unconditional support continued with extreme efforts that helped us with a $50,000 NIH I-corps grant, which resulted in additional NCI grant funding of $150,000 to extend our diagnostic test application to non-small cell lung cancer.”

– Nahid Razi, Founder/CEO


Economic Impact:

Areas of Assistance:

  • Capital Infusion: $500,000

  • Obtain Grant Funding

  • Grant Applications

  • Strategic Planning

Description of Business:

AccuDava’s research has the potential to create a paradigm shift in cancer treatment decision making that would ultimately save millions of lives.
Many cancer patients do not survive as a result of tumors that do not respond to commonly used chemotherapy drugs, but AccuDava’s method solves this unmet need in cancer chemotherapy. The company’s diagnostic test saves lives by identifying chemotherapy-resistant patients prior to any drugs being administered, saving people from unnecessary suffering from ineffective drugs and giving patients and doctors a chance to find treatments that work. For more information, please see

Use of Capital Infusion Funds:

The financing was utilized by the company to fund further research and development of its diagnostic test.


La Jolla, CA 92037